| Balance sheet (USD) | FY 2026 ended May 31, 2026 | FY 2025 ended May 31, 2025 | FY 2024 ended May 31, 2024 | FY 2023 ended May 31, 2023 | FY 2022 ended May 31, 2022 | FY 2021 ended May 31, 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 53.86M | 55.89M | 76.06M | 44.62M | 28.82M | 48.16M |
| Receivables | 48.33M | 42.89M | 43.61M | 52.83M | 52.30M | 35.41M |
| Inventory | 52.44M | 62.01M | 60.62M | 55.33M | 51.39M | 48.61M |
| Total current assets | 163.39M | 168.32M | 193.25M | 163.54M | 143.34M | 140.88M |
| Property, plant and equipment | 27.10M | 32.30M | 35.67M | 44.38M | 45.01M | 37.07M |
| Goodwill and intangibles | 67.21M | 69.12M | 77.38M | 270.38M | 353.44M | 370.29M |
| Total assets | 267.16M | 280.14M | 317.67M | 532.64M | 552.75M | 561.44M |
| Accounts payable | 31.51M | 33.29M | 37.75M | 40.45M | 28.05M | 19.63M |
| Total current liabilities | 74.72M | 76.20M | 91.16M | 83.83M | 74.32M | 57.58M |
| Long-term debt | 0 | 49.82M | 25.00M | |||
| Total liabilities | 96.34M | 97.17M | 112.08M | 154.34M | 128.26M | 121.98M |
| Retained earnings | -465.94M | -429.20M | -395.20M | -210.85M | -158.41M | -131.87M |
| Shareholders' equity | 170.82M | 182.97M | 205.59M | 378.30M | 424.49M | 439.46M |
| Total debt | 0 | 49.82M | 25.00M | |||
| Net debt | -76.06M | 5.20M | -3.83M |
From Angiodynamics Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.